Stay updated on IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision label, v3.3.3, was added to the page. The HHS Vulnerability Disclosure link was removed from the footer.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe history now shows the addition of a new revision label v3.3.2 and the removal of v3.3.1, a minor software-version update with no impact on page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe history shows a new revision entry: Revision: v3.3.1. It also shows the removal of Revision: v3.2.0, reflecting a page version update in the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange Detected- The government funding/operating status notice was removed from the page.SummaryDifference0.5%

- Check63 days agoChange DetectedThe update appears to be a cosmetic refresh of the history page with no substantive changes to trial data (status, design, or contacts). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference11%

Stay in the know with updates to IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.